David Cox advises owners, executives and boards of emerging and growth companies in key corporate events, such as capital formation, private equity transactions, acquisitions and change in control transactions. David has advised on more than 400 transactions for private and public companies throughout the United States, including pioneers in their industry such as Addus Homecare, American HomePatient, Berlitz, Central Parking, ClinTrials, Pharmerica and Shoals Technologies.
His representation covers a broad range of healthcare sectors, with particularly deep experience advising laboratory testing and life sciences, medical distribution and health software companies. A substantial portion of his representation also involves clients in financial services and financial technology and software. He also has advised clients in numerous other industries including retail services, logistics and distribution, technology and energy.
David’s practice includes:
- Mergers & Acquisitions – Advising clients on M&A transactions, including auction processes and representing both private equity and strategic buyers and sellers. Typically, his focus is on middle market transactions up to $1 billion.
- Private Equity – Counseling private equity backed companies, with a particular focus on navigating the interplay between private equity/venture capital investors and portfolio company executive teams.
- Board and Executive Advisory – Representing board of directors, special committees and individual executives of both public and private companies, including special situations such as going private transactions, special committee representation, audit committee investigations and takeover transactions.
Prior to joining Bass, Berry & Sims, David was a shareholder and executive committee member at Harwell Howard Hyne Gabbert & Manner, P.C.